The symptoms may appear anywhere from 2-21 days after a person is exposed to ebola-virus. People usually experience symptoms within 8-10 days.
The standard treatment for Ebola HF remains limited to supportive therapy.
Ebola virus disease (EVD; also Ebola hemorrhagic fever, or EHF), or simply Ebola, is a disease of humans and other primates caused by ebola-viruses. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Signs and symptoms typically start between two days and three weeks after contracting the virus with a fever, sore throat, muscle pain, and headaches. Then, vomiting, diarrhea and rash usually follow, along with decreased function of the liver and kidneys. At this time some people begin to bleed both internally and externally. Ebola hemorrhagic fever is one of a number of Viral Hemorrhagic Fevers. It is a severe and many times fatal disease in people and non-human primates such as gorillas, chimpanzees, and monkeys. Ebola HF is caused by infection with a virus of the family, 'Filoviridae,' genus Ebola-virus. When an infection happens, symptoms usually start quickly.
The first Ebola-virus species was discovered in the year 1976 in what has become the Democratic Republic of the Congo near the Ebola River. Since that time, outbreaks have appeared sporadically. The Ministries of Health (MoH) of both Liberia and Guinea and the World Health Organization (WHO) have reported an outbreak of Ebola HF in several Liberian and Guinean districts.
There are 5 identified subspecies of Ebola-virus. 4 of the 5 have caused disease in people:
The 5th subspecies, Reston virus, has caused disease in non-human primates, but not in people.
The natural reservoir host of ebola-viruses is something that remains unknown at this time. On the basis of available evidence and the nature of similar viruses; however, researchers believe the virus is, 'zoonotic,' or, 'animal-borne,' with bats being the most likely reservoir. 4 of the 5 subtypes happen in an animal host native to the continent of Africa.
A host of similar species is most likely associated with Reston virus, which was isolated from infected cynomolgous monkeys imported to America and Italy from the Philippines. A number of workers in the Philippines and in American holding facility outbreaks became infected with the virus, yet did not become sick.
Due to the fact that the natural reservoir of ebola-viruses has yet to be proven, the manner in which the virus first appears in a person at the beginning of an outbreak remains unknown. Researchers; however, have hypothesized that the first person becomes infected through contact with an infected animal. When an infection does happen in people, there are a number of ways in which the virus may be transmitted to others. These ways may include direct contact with the blood or secretions of a person who is infected, or exposure to objects such as needles that have become contaminated with infected secretions.
The viruses that cause Ebola HF are many times spread through family members and friends because they come in close contact with infectious secretions while caring for others who are sick. During outbreaks of Ebola HF, the disease spreads rapidly within healthcare settings such as in hospitals or clinics. Exposure to ebola-viruses may happen in healthcare settings where staff members are not wearing appropriate protective gear such as gloves, gowns, and masks.
Proper cleaning and disposal of instruments such as syringes and needles is important. If instruments are not disposable they need to be sterilized before they are used again. Without adequate sterilization of these instruments, virus transmission might continue and amplify the outbreak.
Several symptoms of Ebola HF exist. The symptoms may appear anywhere from 2-21 days after a person is exposed to ebola-virus. People usually experience symptoms within 8-10 days.
Symptoms of Ebola HF May Include:
Some people who become sick with Ebola HF do recover; other people do not. The reasons why are not fully understood. It is known; however, that people who die from Ebola HF usually do not develop a significant immune response to the virus at the time of their death.
Diagnosing Ebola HF in a person who has become infected for only a few days is hard because the early symptoms, such as a skin rash and red eyes, are non-specific to ebola-virus infection and are often times seen in people with more common diseases. If a person presents with early symptoms of Ebola HF; however, and there is reason to believe that Ebola HF should be considered, the person should be isolated and public health professionals should be notified. Samples from the person may then be collected and tested in order to confirm the infection.
The standard treatment for Ebola HF remains limited to supportive therapy. The therapy consists of balancing the person's electrolytes and fluids, maintaining their oxygen status and blood pressure, as well as treating them for any complicating infections. Timely treatment of Ebola HF is important yet challenging because the disease is hard to diagnose clinically in the early stages of infection. Early symptoms such as fever and headache are non-specific to ebola-virus and infection might be initially misdiagnosed.
Contact tracing is finding everyone who comes in direct contact with a sick Ebola patient. Contacts are watched for signs of illness for 21 days from the last day they came in contact with the Ebola patient. If the contact develops a fever or other Ebola symptoms, they are immediately isolated, tested, provided care, and the cycle starts again, all of the new patient's contacts are found and watched for 21 days. Contact tracing finds new cases quickly so they can be isolated, stopping further spread of Ebola.
Prevention of Ebola HF presents several challenges. The fact that it is still unknown exactly how people are infected with Ebola HF means there are few established primary prevention measures. When infections do occur, there is increased risk of transmission, particularly in healthcare settings. Due to this increased risk, healthcare workers must be able to recognize an infection with Ebola HF and be ready to employ practical viral hemorrhagic fever isolation precautions or barrier nursing techniques. They should also have the ability to request diagnostic testing or to prepare samples for shipping and testing at other locations. Barrier nursing techniques include the following:
The goal of these techniques is to avoid contact with the secretions or blood of a person who is infected with the virus. If a person with Ebola HF dies, it is just as important that direct contact with the body of the person who has died be prevented.
Experts are calling for massive global response to tackle Ebola. The outbreak which began in December 2013 now spans five countries in West Africa and has so far killed nearly 2000 people, with the WHO predicting that 20,000 may become infected. (Sept. 2014). In cities like Monrovia in Liberia, the infection has led to the closure of most health facilities, and as a result, untreated injuries and illnesses have caused further loss of life. Exponential growth in numbers makes tracing and surveillance for Ebola increasingly difficult, and that cases could double every fortnight if the situation remains the same.
Professor Piot, Director of the London School of Hygiene & Tropical Medicine, writes: "This fast pace of Ebola's spread is a grim reminder that epidemics are a global threat and that the only way to get this virus under control is through a rapid response at a massive global scale - much stronger than the current efforts."
This is an opportune time to accelerate evaluation of experimental therapies and vaccines. With the WHO announcing that compassionate use of experimental therapies is ethically justified, even if they have not been tested in humans - An exceptional crisis requires an exceptional response.
New protocol for imaging patients with Ebola:
In a breakthrough that could substantially improve physicians' ability to rapidly evaluate patients with suspected Ebola, radiologists at Emory University Hospital have devised a protocol for obtaining chest radiographs using portable computed radiography. The protocol not only limits the exposure of personnel and equipment to body fluids, it also minimizes the risk of contaminants leaving the isolation unit by use of thorough decontamination procedures. The step-by-step protocol is outlined in an article published ahead of print in the American Journal of Roentgenology at www.ajronline.org/doi/abs/10.2214/AJR.14.14041
Experts question aspects of certain Ebola guidelines (Wiley):
Various guidelines for caring for patients infected with Ebola virus are being issued from different national and state public health authorities, professional societies, and individual hospitals. Experts are questioning aspects of some of the guidelines that go beyond current CDC recommendations, especially those that call for suspending certain routine lab tests.
The authors of a Transfusion commentary note that most individuals with suspected Ebola virus disease will have a fever due to another cause, and forgoing such testing may compromise patients' health more than any reduction in the risks to laboratory personnel.
The authors also state that it is imperative for all laboratory directors to work with institutional infection control and safety personnel to evaluate their hospital policies on potentially infectious patients in order to provide a safe environment for their patients and employees.
"We are anxious for a balanced, thoughtful discussion of the best way to prepare for the potential of increasing numbers of Ebola suspects across a spectrum of healthcare institutions in the developed world, and believe that the key is recognition of risk and application of well characterized infection prevention and control recommendations," said co-author Dr. Louis Katz. "Suspending aspects of care or automatically transferring patients to other facilities may not be an effective response to the prevention of healthcare-associated transmission if more cases are repatriated than we have seen to date."
Screening at U.S. Airports of Travelers From Ebola Outbreak Countries:
U.S. Senator Lamar Alexander (R-Tenn.) today urged President Obama to accelerate the United States response to the West African Ebola epidemic.
"I am today urging President Obama to take two steps to accelerate our country's response to the Ebola epidemic:
The senator said: "We must take the deadly, dangerous threat of Ebola in West Africa as seriously as we take the ISIS threat in the Middle East. The spread of this disease requires a more urgent response from the United States and other countries."
Ebola may be deadlier and more widespread than we think:
The current Ebola outbreak in West Africa has grown exponentially since May, indicating inadequate global response. A new analysis indicates that the outbreak's fatality rate is over 70% - rather than 50% as previously claimed by the World Health Organization - and that the total number of affected individuals could exceed 1 million by early next year.
As long as the number of infected people rises exponentially, the likelihood of exporting Ebola to other countries does as well.
"The disease itself hasn't changed, with essentially the same fatality rate and transmissibility as ever. What is different is the number of sickened individuals," said Dr. Allen Hunt, author of the Complexity paper. "If trends continue a few more months, the global community could be forced into a terrible ethical dilemma - either risking the escape of Ebola to other poor, war-torn countries, or sealing off borders to countries in West Africa, with unimaginable humanitarian consequences."
According to the World Health Organization (WHO), Ebola is one of the deadliest viruses known to humankind, and the current outbreak is the largest in history, according to the U.S. Centers for Disease Control and Prevention (CDC).